Value of Fused ¹⁸F-Choline-PET/MRI to Evaluate Prostate Cancer Relapse in Patients Showing Biochemical Recurrence after EBRT: Preliminary Results

Table 3

Lesion-based analysis and sensitivity in lesion detection according to different sites of recurrence/metastases (i.e., local recurrence, lymph nodes, and bone) obtained by mMRI, ¹⁸F-Choline PET/MRI, CeCT, and ¹⁸F-Choline PET/CT.

	mMRI	^18F-Choline-PET/MRI	CeCT	^18F-Choline-PET/CT
Prostate gland
Sensitivity	6/6 (100%)	6/6 (100%)	1/6 (17%)	4/6 (67%)
Specificity	14/15 (93%)	15/15 (100%)	15/15 (100%)	15/15 (100%)
Accuracy	20/21 (95%)	21/21 (100%)	16/21 (76%)	19/21 (90%)
Lymph nodes
Sensitivity	27/40 (67%)	40/40 (100%)	23/40 (57%)	40/40 (100%)
Specificity	15/15 (100%)	15/15 (100%)	15/15 (100%)	15/15 (100%)
Accuracy	42/55 (76%)	55/55 (100%)	38/55 (69%)	55/55 (100%)
Bone
Sensitivity	14/14 (100%)	14/14 (100%)	6/14 (43%)	13/14 (93%)
Specificity	11/12 (92%)	11/12 (92%)	12/12 (100%)	11/12 (92%)
Accuracy	25/26 (96%)	25/26 (96%)	18/26 (69%)	25/26 (96%)